A rare case of mistaken identity - Historical blood group saved the situation

QR Code

A rare case of mistaken identity - Historical blood group saved the situation

Enregistré dans:

Détails bibliographiques
Auteurs principaux:	Anand Deshpande, R Basavanna
Format:	article
Langue:	EN
Publié:	Wolters Kluwer Medknow Publications 2021
Sujets:	Diseases of the blood and blood-forming organs RC633-647.5
Accès en ligne:	https://doaj.org/article/2a9abb95bd914fe4ac80f7a7341d1c3b
Tags:	Ajouter un tag Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires

EVALUATION OF THE RELATIONSHIP OF ABO BLOOD GROUPS WITH MIS-C
par: Fatma Burçin KURTİPEK, et autres
Publié: (2021)

A RARE AND COMPLEX CAUSE OF IMPOTENCE POEMS SYNDROME
par: Buğra Sağlam, et autres
Publié: (2021)

A RARE CASE: POSTTRANSPLANT NK/T CELL LYMPHOMA
par: Pınar Tığlıoğlu, et autres
Publié: (2021)

A RARE CAUSE OF SIDEROBLASTIC ANEMIA: TRNT1 MUTATION
par: Fatma Tuba YILDIRIM, et autres
Publié: (2021)

ACTINOMYCES ODONTOLYTICUS: A RARE CAUSE OF PEDIATRIC FEBRILE NEUTROPENIA
par: Meric KAYMAK CIHAN, et autres
Publié: (2021)

A RARE CAUSE OF ANEMIA IN ADULTHOOD CONGENITAL DYSERYTHROPETIC ANEMIA
par: Buğra Sağlam, et autres
Publié: (2021)

A Rare Cause of Acquired Factor X Deficiency in an 87-Year-Old Female
par: Ayrton Bangolo, et autres
Publié: (2021)

A VERY RARE CAUSE OF DIARRHEA IN A CHEMOTHERAPY-INDUCED NEUTROPENIC PATIENT: PELLAGRA
par: Fatma YILMAZ, et autres
Publié: (2021)

A RARE ASSOCIATION IN A CASE WITH HEREDITARY SPHEROCYTOSIS: SPECTRIN BETA (SPTB) AND JAK-2 MUTATION
par: Fatma YILMAZ, et autres
Publié: (2021)

A new era in blood and lymphatic cancer biology and therapy
par: David Dingli
Publié: (2011)

DOES BLOOD TYPE HAVE AN EFFECT ON THE COURSE OF COVID-19?
par: Fatma YILMAZ, et autres
Publié: (2021)

SYNTHETIC BIOLOGY MEETS PRECISION MEDICINE: DRUG REPURPOSING FOR BLOOD CANCER PRECISION MEDICINE
par: Deepak Balaji Thimiri Govindaraj Thimiri Govindaraj
Publié: (2021)

Summary of Joint European Hematology Association (EHA) and EuroBloodNet Recommendations on Diagnosis and Treatment of Methemoglobinemia
par: Achille Iolascon, et autres
Publié: (2021)

COMPARABLE OUTCOMES OF ALLOGENEIC PERIPHERAL BLOOD VERSUS BONE MARROW HEMATOPOIETIC STEM CELL TRANSPLANTATION IN CHILDREN
par: AYÇA KOCA YOZGAT, et autres
Publié: (2021)

Clinical relevance of hepatitis B core total antibody in the detection of occult hepatitis B infection in patients with liver disease and blood donors
par: Vijeta Bajpai, et autres
Publié: (2021)

Trends in the treatment of cutaneous T-cell lymphoma &ndash; critical evaluation and perspectives on vorinostat
par: Zhang CL, et autres
Publié: (2012)

MicroRNA dysregulation in B-cell non-Hodgkin lymphoma
par: Lim EL, et autres
Publié: (2013)

Critical appraisal of belinostat in the management of T-cell lymphoma – patient considerations
par: Bodiford A, et autres
Publié: (2015)

The expanding role of bendamustine in chronic lymphocytic leukemia
par: Nair KS, et autres
Publié: (2015)

Bortezomib in autoimmune hemolytic anemia and beyond
par: Raffaella Pasquale, et autres
Publié: (2021)

Life-Threatening Retroperitoneal Hematoma in a Patient with COVID-19
par: Monarch Shah, et autres
Publié: (2021)

A method to determine if more than surrogate outcomes were improved: The EMR glitch experiment
par: Jennifer Gill, et autres
Publié: (2020)

All bleeding matters … but the details may not
par: Sarah H. O’Brien
Publié: (2020)

The Use of Etoposide, Ara-Cytarabine, and Melphalan (EAM) Conditioning Chemotherapy in Autologous Stem Cell Transplantation (ASCT) for a Patient with Relapsed Hodgkin’s Lymphoma
par: Eko A. Pangarsa, et autres
Publié: (2021)

PP Transcon 2020 Abstracts Compilation
Publié: (2021)

Positive/external control of rapid diagnostic tests: A step forward in malaria screening
par: Rasika D Setia, et autres
Publié: (2021)

Oration - Dr Sanmukh Joshi
Publié: (2021)

OP Transcon 2020 Abstracts Compilation
Publié: (2021)

TRANSCON 2020 45th Annual Conference ISBTI 27th & 28th Feb 2021
Publié: (2021)

Long-term safety and efficacy of dasatinib in the treatment of chronic-phase chronic myeloid leukemia patients resistant or intolerant to imatinib
par: Shoumariyeh K, et autres
Publié: (2014)

MYC as therapeutic target in leukemia and lymphoma
par: Cortiguera MG, et autres
Publié: (2015)

Clinical potential of carfilzomib in the treatment of relapsed and refractory multiple myeloma
par: Gupta VA, et autres
Publié: (2013)

Optimal management of endemic Burkitt lymphoma: a holistic approach mindful of limited resources
par: Moormann AM, et autres
Publié: (2014)

Peripheral T cell lymphoma: clinical utility of romidepsin
par: Sawey K, et autres
Publié: (2012)

The evaluation and optimal use of rituximab in lymphoid malignancies
par: Smolewski P, et autres
Publié: (2012)

Impact of pharmacokinetics to reduce bleeding in a cohort of patients with severe hemophilia A in a personalized comprehensive management program
par: Samuel sarmiento Doncel, et autres
Publié: (2021)

Ultrastructural alterations of megakaryocytes in thrombocytopenia: A review of 43 cases
par: Brian Eyden, et autres
Publié: (2021)

Regulation of megakaryopoiesis by bone marrow macrophage polarization
par: Ming Hou
Publié: (2021)

The correlation between Flt3-ITD mutation in dendritic cells with TIM-3 expression in acute myeloid leukemia
par: Hooriyeh Shapoorian, et autres
Publié: (2021)

Immune targeted therapy for diffuse large B cell lymphoma
par: Yaxin Zheng, et autres
Publié: (2021)